Today: 30 June 2026

Michał Rogucki

Michał Rogucki is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic developments. A graduate of Humboldt University of Berlin, he previously worked in investment research and market analysis before transitioning to financial journalism. He covers the trends and events that matter most to investors worldwide.

Xero share price closes higher; traders eye Australia GDP and RBA signals next week

Xero share price closes higher; traders eye Australia GDP and RBA signals next week

Sydney, Feb 27, 2026, 17:50 AEDT — Market closed. Xero Ltd climbed 1.0% to finish Friday at A$83.14, as the accounting software maker continued its recent rally. The company had released figures pointing to Australian small businesses posting their best sales and jobs numbers in two years. Shares moved in a range of A$80.66 to A$84.64, with roughly 2.27 million changing hands.
27 February 2026
Commonwealth Bank (CBA) share price drops as AUSTRAC eyes suspected $1bn mortgage fraud

Commonwealth Bank (CBA) share price drops as AUSTRAC eyes suspected $1bn mortgage fraud

Sydney, Feb 27, 2026, 16:55 AEDT — After-hours Shares in Commonwealth Bank of Australia slipped Friday, closing at A$173.87, down 1.9% after Capital Brief reported that AUSTRAC, the country’s financial crimes watchdog, is looking into whether suspected fraudulent home loans at the lender were channeled for money laundering. Still, the stock has risen about 10% this year.
27 February 2026
Hims & Hers stock steadies in premarket as Citi cuts target, SEC probe keeps GLP-1 risks in play

Hims & Hers stock steadies in premarket as Citi cuts target, SEC probe keeps GLP-1 risks in play

New York, Feb 26, 2026, 08:43 EST — Premarket Hims & Hers Health shares nudged 0.3% higher ahead of Thursday’s open, building on Wednesday’s 2.3% advance. The telehealth firm wrapped up the last session at $15.82, after trading in a range from $15.06 to $16.46 during the day. On Tuesday, the stock had dropped to $13.74.
1 34 35 36 37 38 42

Stock Market Today

  • JPMorgan Chase Gets Zacks Rank Upgrade as Earnings Estimates Climb
    June 30, 2026, 1:31 PM EDT. Zacks upgraded JPMorgan Chase & Co. (JPM) to a #2 (Buy) rating after a rise in earnings estimates. The Zacks system looks only at sell-side analyst forecast changes to call stock moves. That upgrade signals better business trends for JPMorgan and may lift the shares. Institutional investors focus on earnings estimates when pricing stocks and often trade hard on new projections. Zacks Rank, backed by historical returns, is aimed at giving retail investors a way to track those estimate trends.
Go toTop